Abstract
Introduction
Few studies have examined outcomes in immunosuppressed patients who develop melanoma. The purpose of this study is to compare survival in immunosuppressed patients who developed melanoma with that in patients with melanoma who are not immunosuppressed.
Methods
Immunosuppressed patients were defined as having solid organ transplant, lymphoma, leukemia, or human immunodeficiency virus prior to diagnosis of melanoma. Patients with cutaneous melanoma with and without immunosuppression were identified retrospectively from the Ontario Cancer Registry (2007–2015) and linked with administrative databases to identify demographics, treatment, and outcomes. Immunosuppressed patients were matched with non-immunosuppressed patients based on age at diagnosis, sex, birth year, stage at diagnosis, and propensity score. The primary outcome was overall survival. Multivariable Cox proportional hazard regression was used to identify factors associated with survival.
Results
Baseline characteristics were well balanced in 218 immunosuppressed patients matched to 436 controls. Of the patients, 186 (28.4%) were female, and median age at melanoma diagnosis was 69 (interquartile range, IQR 59–78) years. Three-year overall survival (OS) was 65% for immunosuppressed patients and 79% for non-immunosuppressed patients. Melanoma was the leading cause of death for both groups. On multivariable analysis, immunosuppression was associated with increased mortality [hazard ratio (HR) 1.70, 95% confidence interval (CI) 1.30–2.23]. Adequate treatment (HR 0.36, 95% CI 0.22–0.58) and dermatologist visits either before (HR 0.52, 95% CI 0.36–0.73) or after (HR 0.61, 95% CI 0.41–0.90) melanoma diagnosis were associated with improved OS.
Conclusions
Immunosuppressed patients who develop melanoma have worse outcomes when matched to non-immunosuppressed patients. This decrease in survival appears related to the underlying condition rather than diagnosis of melanoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kubica AW, Brewer JD. Melanoma in immunosuppressed patients. Mayo Clin Proc. 2012;87:991–1003.
Lindelof B, Sigurgeirsson B, Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143:513–519.
Mudigonda T, Levender MM, O’Neill JL, et al. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: A review of single‐ and multicenter retrospective studies from 2006 to 2010. Dermatol Surg. 2013;39:345–364.
Vajdic CM, van Leeuwen MT, Webster AC, et al. Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev. 2009;18:2297–2303.
Le Mire L, Hollowood K, Gray D, et al. Melanomas in renal transplant recipients. Br J Dermatol. 2006;154:472–477.
Brewer JD, Habermann TM, Shanafelt TD. Lymphoma‐associated skin cancer: Incidence, natural history, and clinical management. Int J Dermatol. 2014;53:267–274.
Brewer JD, Shanafelt TD, Call TG, et al. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia. Int J Dermatol. 2015;54:287.
Famenini S, Martires KJ, Zhou H, et al. Melanoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma. J Am Acad Dermatol. 2015;72:78–84.
McKenna DB, Stockton D, Brewster DH, et al. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: A population-based retrospective cohort study in Scotland. Br J Cancer. 2003;88:74–78.
Olsen CM, Lane SW, Green AC. Increased risk of melanoma in patients with chronic lymphocytic leukaemia: Systematic review and meta-analysis of cohort studies. Melanoma Res. 2016;26:188–194.
Kind GM, VonRoenn J, Jansen DA, et al. Human immunodeficiency virus infection and subsequent melanoma. Ann Plast Surg. 1996;37:273–277.
Olsen CM, Knight LL, Green AC. Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies. PLoS ONE. 2014;9:e95096.
Wilkins K, Turner R, Dolev JC, et al. Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol. 2006;54:189–206.
Crum-Cianflone N, Hullsiek KH, Satter E, et al. Cutaneous malignancies among HIV-infected persons. Arch Intern Med. 2009;169:1130–1138.
Antoniou T, Zagorski B, Loutfy MR, Strike C, Glazier RH. Validation of case-finding algorithms derived from administrative data for identifying adults living with human immunodeficiency virus infection. PLOS One. 2011;6(6):e21748.
Johnson DB, Smalley KSM, Sosman JA. Molecular pathways: Targeting NRAS in melanoma and acute myelogenous leukemia. Clin Cancer Res. 2014;20:4186–4192.
Zattra E, Belloni Fortina A, Bordignon M, et al. Immunosuppression and melanocyte proliferation. Melanoma Res. 2009;19:63–68.
Look Hong NJ, Cheng SY, Baxter NN, et al. Melanoma patterns of care in Ontario: a call for a strategic alignment of multidisciplinary care. J Surg Oncol. 2018;117:597–617.
Weiner JP, Starfield BH, Steinwachs DM, et al. Development and application of a population-oriented measure of ambulatory care case-mix. Med Care 1991;29:452–472.
The Johns Hopkins University. The Johns Hopkins Adjusted Clinical Groups (ACG) System. 1997. http://www.acg.jhsph.org.
Bovenschen HJ, Tjioe M, Vermaat H, et al. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals. Br J Dermatol. 2006;154:880–884.
Reid RJ, MacWilliam L, Verhulst L, et al. Performance of the ACG case-mix system in two Canadian provinces. Med Care. 2001;39:86–99.
Reid RJ, Roos NP, MacWilliam L, et al. Assessing population health care need using a claims‐based ACG morbidity measure: A validation analysis in the province of Manitoba. Health Serv Res. 2002;37:1345–1364.
Brewer JD, Christenson LJ, Weenig RH, et al. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma. Dermatol Surg. 2010;36:368–376.
Velez NF, Karia PS, Vartanov AR, et al. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia. JAMA Dermatol. 2014;150:280–287.
McIntosh BC, Ariyan S, Esche G, et al. Metachronous primary melanoma and lymphoma. Ann Plast Surg. 2010;64:229–232.
Donahue T, Lee CY, Sanghvi A, et al. Immunosuppression is an independent prognostic factor associated with aggressive tumor behavior in cutaneous melanoma. J Am Acad Dermatol. 2015;73:461–466.
Matin RN, Mesher D, Proby CM, et al. Melanoma in organ transplant recipients: Clinicopathological features and outcome in 100 cases. Am J Transplant. 2008;8:1891–1900.
Brewer JD, Christenson LJ, Weaver AL, et al. Malignant melanoma in solid transplant recipients: Collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol. 2011;147:790–796.
Brewer JD, Shanafelt TD, Otley CC, et al. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study. J Clin Oncol. 2012;30:843–849.
Rodrigues LKE. Altered clinical course of malignant melanoma in HIV-positive patients. JAMA 2002;288:1217.
Siegel RL, Miller KD, Jemal, A. Cancer statistics, 2016. CA: Cancer J Clin. 2016;66(1): 7–30.
Sharon CE, Sinnamon AJ, et al. Association of marital status with T stage at presentation and management of early-stage melanoma. JAMA Dermatol. 2018;154(5):574–580.
Andrews MC, Turner N, Boyd J, et al. Cellular mechanisms underlying complete hematological response of chronic myeloid leukemia to BRAF and MEK1/2 inhibition in a patient with concomitant metastatic melanoma. Clin Cancer Res. 2015;21:5222–5234.
Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D. RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer. 2011;11:671–774.
Jakob JA, Bassett RL, Ng CS, et al. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer 2012;118:4014–4023.
Richert S, Bloom EJ, Flynn K, et al. Widespread eruptive dermal and atypical melanocytic nevi in association with chronic myelocytic leukemia: case report and review of the literature. J Am Acad Dermatol. 1996;35:326–329.
Madeleine D, Lori L, Ronald PR, et al. Eruptive dysplastic nevi associated with human immunodeficiency virus infection. Arch Dermatol. 1989;125:125–136.
Grob JJ, Bastuji-Garin S, Vaillant L, et al. Excess of nevi related to immunodeficiency: a study in HIV-infected patients and renal transplant patients. J Investig Dermatol. 1996;107:694–697.
Acknowledgement
Academic Enrichment Fund for General Surgery at Sunnybrook Health Sciences Centre. Mahaffy Research Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None of the above authors have any conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
ICD-O-3 morphology and behavior codes for melanoma
Code | Description |
|---|---|
8720/3 | Malignant melanoma, NOS; melanoma, NOS |
8721/3 | Nodular melanoma |
8722/3 | Balloon cell melanoma |
8723/3 | Malignant melanoma, regressing |
8728/3 | Meningeal melanomatosis |
8730/3 | Amelanotic melanoma |
8740/3 | Malignant melanoma in junctional nevus |
8741/3 | Malignant melanoma in precancerous melanosis |
8742/3 | Lentigo maligna melanoma; Malignant melanoma in Hutchinson melanotic freckle |
8743/3 | Superficial spreading melanoma |
8744/3 | Acral lentiginous melanoma, malignant |
8745/3 | Desmoplastic melanoma, malignant; Neurotropic melanoma, malignant; Desmoplastic melanoma, amelanotic |
8746/3 | Mucosal lentiginous melanoma |
8761/3 | Malignant melanoma in giant pigmented nevus; Malignant melanoma in congenital melanocytic nevus |
8770/3 | Mixed epithelioid and spindle cell melanoma |
8771/3 | Epithelioid cell melanoma |
8772/3 | Spindle cell melanoma, NOS |
8773/3 | Spindle cell melanoma, type A |
8774/3 | Spindle cell melanoma, type B |
ICD-O-3 topography codes
Code | Description |
|---|---|
C00.0 | External upper lip |
C00.1 | External lower lip |
C44.0 | Skin of lip, NOS |
C44.1 | Eyelid |
C44.2 | External ear |
C44.3 | Skin of other and unspecified parts of face |
C44.4 | Skin of scalp and neck |
C44.5 | Skin of trunk |
C44.6 | Skin of upper limb and shoulder |
C44.7 | Skin of lower limp and hip |
C44.8 | Overlapping lesion of skin |
C44.9 | Skin, NOS |
C49.0 | Connective, subcutaneous, and other soft tissues of head, face, and neck |
C49.1 | Connective, subcutaneous, and other soft tissues of upper limb and shoulder |
C49.2 | Connective, subcutaneous, and other soft tissues of lower limb and hip |
C49.3 | Connective, subcutaneous, and other soft tissues of thorax |
C49.9 | Connective, subcutaneous, and other soft tissues, NOS |
C50.1 | Central portion of breast |
C50.9 | Breast, NOS |
C51.0 | Labium majus |
C51.1 | Labium minus |
C51.2 | Clitoris |
C60.0 | Prepuce |
C60.9 | Penis, NOS |
C63.2 | Scrotum, NOS |
C77.3 | Lymph nodes of axilla or arm |
C77.4 | Lymph nodes of inguinal region or leg |
C77.9 | Lymph node, NOS |
Morphology Codes for Lymphoma
9590/3 9591/3 9596/3 9597/3 9650/3 9651/3 9652/3 9653/3 9654/3 9655/3 9659/3 9663/3 9664/3 9665/3 9667/3 9670/3 9671/3 9673/3 9675/3 9678/3 9679/3 9680/3 9684/3 9687/3 9688/3 9689/3 9690/3 9691/3 9695/3 9698/3 9699/3 9700/3 9702/3 9705/3 9708/3 9709/3 9712/3 9714/3 9716/3 9717/3 9718/3 9719/3 9725/3 9726/3 9735/3 9737/3 9738/3
Morphology Codes for Leukemia
9742/3 9800/3 9801/3 9805/3 9806/3 9807/3 9808/3 9809/3 9811/3 9812/3 9813/3 9814/3 9815/3 9816/3 9817/3 9818/3 9820/3 9823/3 9826/3 9827/3 9831/3 9832/3 9833/3 9834/3 9840/3 9860/3 9861/3 9863/3 9865/3 9866/3 9867/3 9869/3 9870/3 9871/3 9872/3 9873/3 9874/3 9875/3 9876/3 9891/3 9895/3 9896/3 9897/3 9897/3 9910/3 9911/3 9940/3 9945/3 9946/3 9948/3
Consultation OHIP fee codes
Code | Fee code description |
|---|---|
A025 | CONSULT.-DERM |
A035 | CONSULT.-GEN. SURG |
A085 | CONSULT.-PLASTIC SURG |
Surgical OHIP fee codes
Excision
Code | Fee code description |
|---|---|
R010 | WIDE EXCISION MALIGNANT MELANOMA |
R081 | SURG PROC-SKIN-SURGERY (M.O.H’S TECHNIQUE) |
R990 | SURGICAL PROCEDURE-NOT SPECIFICALLY LISTED-I.C |
Sentinel lymph node biopsy
Code | Fee code description |
|---|---|
Z427 | Sentinel node biopsy, per draining basin |
R914 | LYMPHATIC-NODES-EXC.AUXILLARY/INGUINAL LIMITED |
Lymph node dissection
Code | Fee code description |
|---|---|
R912 | LYMPHATIC-NODES-EXC.ILEOINGUINAL-RADICAL |
R913 | LYMPHATIC-NODES-EXC.-AXILLARY, INGUINAL-RADICAL RESECTION |
J661 | NUCLEAR MED. LYMPHANGIOGRAM |
J861 | NUCLEAR MED. CORRES. TO J661 |
Neck dissection
Code | Fee code description |
|---|---|
R910 | LYMPHATIC-NODES-EXC.-NECK-LIMITED |
R915 | LYMPHATIC NODES-EXC.-MODIFIED RADICAL-PRESERV.SPIN.ACC NERVE |
Flap
Code | Fee code description |
|---|---|
E227 | TEMPORAL ROTATIONAL FLAP-EYELIDS |
R002 | SKIN-ADV. FLAPS-OTHER AREAS-DEFECT-2.1-5 CM. |
R003 | SKIN-ADV. FLAPS-OTHER AREAS-DEFECT-5.1-10 CM. |
R004 | SKIN-ADV. FLAPS-OTHER AREAS-DEFECT OVER 10 CM. |
R005 | SKIN-MYOCUTAN.FLAP-INCL.CLOS-STERNOMASTOID/TENSOR FASC. LATA |
R011 | SKIN-ADV.FLAPS-FACE/NECK/SCALP DEFECT 2.1CM-5CM |
R012 | SKIN-ADV.FLAPS-FACE/NECK/SCALP DEFECT 5.1CM-10CM. |
R045 | SKIN-ROT’N/TRANS./Z PLASTY FACE/NECK/SCALP UP TO 2CM |
R046 | SKIN-ROT’N/TRANS./Z PLASTY FACE/NECK/SCALP 2.1CM TO 5CM |
R047 | SKIN-ROT’N/TRANS./Z PLASTY FACE/NECK/SCALP 5.1CM TO 10CM |
R072 | SKIN-FLAPS-ROT/TRANS/ZPLASTY-OTHER AREAS-LESS THAN 2CM DIAM. |
R073 | SKIN-FLAPS-ROT/TRANS/ZPLASTY-OTHER AREAS-5.1-10 CM.DIAM. |
R074 | SKIN-FLAPS/ROTATIONS/TRANSPOSIT/ZPLASTY MORE THAN 10CM DIAM. |
R075 | SKIN-FLAPS-ROT/TRANS/ZPLASTY-OTHER AREAS-2.1-5 CM.DIAM. |
R076 | SKIN FLAPS—DEFECT MORE THAN 10 CM AVE. DIAM.—FACE/NECK/S |
Graft
Code | Fee code description |
|---|---|
R083 | SKIN-FULL THICKNESS GRAFT-MAJOR-OVER 5CM DIAMETER |
R085 | SKIN-SPLIT THICKNESS GRAFT-MINOR, MEDIUM AREA |
R086 | SKIN-SPLIT THICKNESS GRAFT-INTERMEDIATE, LARGE AREAS |
R087 | SKIN-SPLIT THICKNESS GRAFT-MAJOR-COMPLEX AREA |
R088 | SKIN-SPLIT THICKNESS GRAFT-EXT-MAJOR-LARGE AREAS |
R091 | SKIN-FULL THICKNESS GRAFT-COMPLEX-EYELID, NOSE, LIP, FACE |
R093 | SKIN-FULL THICKNESS GRAFT-INTERMED.-1-5 CM. |
Amputation
Code | Fee code description |
|---|---|
E102 | EYEBALL-EXC.-ENUCLEATION |
R606 | EXTREMITIES-AMPUTATION-THROUGH PHALANX-UPPER |
R610 | EXTREMITIES-AMPUTATION-TRANS METACARPAL-2ND OR 5TH RAY |
R620 | EXTREMITIES-AMPUTATION-LOWER-THROU.METATARSAL/M.P.JOINTS |
R621 | EXTREMITIES-AMPUTATION -RAY SINGLE |
R622 | EXTREMITIES-AMPUTATION -TRANSMETATARSAL/TRANSTARSAL |
CCI procedure codes
Code | Fee code description |
|---|---|
1.CX.80 | Repair, eyelid NEC |
1.CX.80.UD | Repair, eyelid NEC no tissue used (for repair) using full-thickness repair (involving lid margin) |
1.CX.80.UD-XX-A | Repair, eyelid NEC with autograft using full-thickness repair (involving lid margin) |
1.CX.80.UD-XX-E | Repair, eyelid NEC with local flap [e.g., Zplasty] using full-thickness repair (involving lid margin) |
1.CX.80.VP | Repair, eyelid NEC no tissue used (for repair) using partial-thickness repair (involving lid margin) |
1.CX.80.VP-XX-A | Repair, eyelid NEC with autograft using partial-thickness repair (involving lid margin) |
1.CX.80.VP-XX-E | Repair, eyelid NEC with local flap [e.g., Zplasty] using partial-thickness repair (involving lid margin) |
1.CX.80.WJ-XX-A | Repair, eyelid NEC with autograft using excision technique |
1.CX.80.WJ-XX-E | Repair, eyelid NEC with local flap [e.g., Zplasty] using excision technique |
1.CX.87 | Excision partial, eyelid NEC |
1.CX.87.LA-XX-A | Excision partial, eyelid NEC with autograft using simple excision |
1.CX.87.LA-XX-K | Excision partial, eyelid NEC with homograft [e.g., amniotic membrane transplant (AMT) or graft] using simple excision |
1.CX.87.UD | Excision partial, eyelid NEC no tissue used (for repair) using full-thickness excision of lesion (more than one-fourth of lid margin) |
1.CX.87.UD-XX-A | Excision partial, eyelid NEC with autograft full-thickness excision of lesion (more than one-fourth of lid margin) |
1.CX.87.UD-XX-K | Excision partial, eyelid NEC with homograft [e.g., amniotic membrane transplant (AMT) or graft] full-thickness excision of lesion (more than one-fourth of lid margin) |
1.CX.87.VP-XX-A | Excision partial, eyelid NEC with autograft partial-thickness excision of lesion (up to one-fourth of lid margin) |
1.CX.87.VP-XX-K | Excision partial, eyelid NEC with homograft [e.g., amniotic membrane transplant (AMT) or graft] partial-thickness excision of lesion (up to one-fourth of lid margin) |
1.MA.52.LA | Drainage, lymph node(s), head region using open approach |
1.MA.87.LA | Excision partial, lymph node(s), head region using open approach |
1.MC.52.LA | Drainage, lymph node(s), neck region NEC (cervical) using open approach |
1.MC.87.LA | Excision partial, lymph node(s), neck region NEC (cervical) using open approach with no tissue |
1.MC.87.LA-XX-A | Excision partial, lymph node(s), neck region NEC (cervical) using open approach with full-thickness graft |
1.MC.87.LA-XX-E | Excision partial, lymph node(s), neck region NEC (cervical) using open approach with local flap |
1.MC.87.LA-XX-F | Excision partial, lymph node(s), neck region NEC (cervical) using open approach with free distant flap |
1.MC.87.LA-XX-G | Excision partial, lymph node(s), neck region NEC (cervical) using open approach with pedicled distant flap |
1.MC.87.LA-XX-N | Excision partial, lymph node(s), neck region NEC (cervical) using open approach with synthetic tissue |
1.MC.89.LA | Excision total, lymph node(s), neck region NEC (cervical) using open approach with no tissue |
1.MC.89.LA-XX-A | Excision total, lymph node(s), neck region NEC (cervical) using open approach with full-thickness graft |
1.MC.89.LA-XX-E | Excision total, lymph node(s), neck region NEC (cervical) using open approach with local flap |
1.MC.89.LA-XX-F | Excision total, lymph node(s), neck region NEC (cervical) using open approach with free distant flap |
1.MC.89.LA-XX-G | Excision total, lymph node(s), neck region NEC (cervical) using open approach with pedicled distant flap |
1.MC.89.LA-XX-N | Excision total, lymph node(s), neck region NEC (cervical) using open approach with synthetic tissue |
1.MC.91.LA | Excision radical, lymph node(s). neck region NEC (cervical) without tissue radical neck dissection (1) |
1.MC.91.LA-XX-A | Excision radical, lymph node(s). neck region NEC (cervical) using full-thickness graft radical neck dissection |
1.MC.91.LA-XX-E | Excision radical, lymph node(s). neck region NEC (cervical) using local flap radical neck dissection (1) |
1.MC.91.LA-XX-F | Excision radical, lymph node(s). neck region NEC (cervical) using free distant flap radical neck dissection (1) |
1.MC.91.LA-XX-G | Excision radical, lymph node(s). neck region NEC (cervical) using pedicled distant flap radical neck dissection (1) |
1.MC.91.VB | Excision radical, lymph node(s). neck region NEC (cervical) without tissue modified radical neck dissection (2) |
1.MC.91.VB-XX-A | Excision radical, lymph node(s). neck region NEC (cervical) using full-thickness graft modified radical neck dissection |
1.MC.91.VB-XX-E | Excision radical, lymph node(s). neck region NEC (cervical) using local flap modified radical neck dissection (2) |
1.MC.91.VB-XX-F | Excision radical, lymph node(s). neck region NEC (cervical) using free distant flap modified radical neck dissection (2) |
1.MC.91.VB-XX-G | Excision radical, lymph node(s). neck region NEC (cervical) using pedicled distant flap modified radical neck dissection (2) |
1.MD.52.LA | Drainage, lymph node(s), axillary using open approach |
1.MD.87.LA | Excision partial, lymph node(s), axillary using open approach |
1.MD.89.LA | Excision total, lymph node(s), axillary using open approach |
1.MD.89.LA-XX-A | Excision total, lymph node(s), axillary using open approach with full-thickness graft |
1.MD.89.LA-XX-E | Excision total, lymph node(s), axillary using open approach with local flap |
1.MD.89.LA-XX-F | Excision total, lymph node(s), axillary using open approach with free distant flap |
1.MD.89.LA-XX-G | Excision total, lymph node(s), axillary using open approach with pedicled distant flap |
1.MD.89.LA-XX-N | Excision total, lymph node(s), axillary using open approach with synthetic tissue |
1.MH.52.DA | Drainage, lymph node(s), pelvic using endoscopic approach |
1.MH.52.LA | Drainage, lymph node(s), pelvic using open approach |
1.MH.87.DA | Excision partial, lymph node(s), pelvic using endoscopic approach |
1.MH.87.LA | Excision partial, lymph node(s), pelvic using open approach |
1.MH.89.DA | Excision total, lymph node(s), pelvic using endoscopic approach |
1.MH.89.LA | Excision total, lymph node(s), pelvic using open approach |
1.MJ.52.LA | Drainage, lymph node(s), inguinal using open approach |
1.MJ.87.DA | Excision partial, lymph node(s), inguinal using endoscopic approach |
1.MJ.87.LA | Excision partial, lymph node(s), inguinal using open approach |
1.MJ.89.DA | Excision total, lymph node(s), inguinal using endoscopic approach |
1.MJ.89.LA | Excision total, lymph node(s), inguinal using open approach |
1.MJ.91.LA-XX-A | Excision radical, lymph node(s), inguinal using open approach with full-thickness graft |
1.MJ.91.LA-XX-E | Excision radical, lymph node(s), inguinal using open approach with local flap |
1.MJ.91.LA-XX-F | Excision radical, lymph node(s), inguinal using open approach with free distant flap |
1.MJ.91.LA-XX-G | Excision radical, lymph node(s), inguinal using open approach with pedicled distant flap |
1.MJ.91.LA-XX-N | Excision radical, lymph node(s), inguinal using open approach with synthetic tissue |
1.UI.93 | Amputation, first phalanx of hand |
1.UI.93.LA | Amputation, first phalanx of hand using simple apposition technique [e.g., suturing] (for closure of stump) |
1.UI.93.LA-XX-A | Amputation, first phalanx of hand using autograft [e.g., full-thickness skin graft or bone graft] (for closure of stump) |
1.UI.93.LA-XX-B | Amputation, first phalanx of hand using split-thickness skin graft (for closure of stump) |
1.UI.93.LA-XX-E | Amputation, first phalanx of hand using local flap [e.g., V–Y plasty] |
1.UI.93.LA-XX-F | Amputation, first phalanx of hand using free flap [e.g., toe-to-finger flap] |
1.UI.93.LA-XX-G | Amputation, first phalanx of hand using pedicled transposition flap [e.g., finger rotation flap] |
1.UJ.93 | Amputation, phalanx of hand |
1.UJ.93.LA | Amputation, other phalanx of hand using simple apposition technique [e.g., suturing] (for closure of stump) |
1.UJ.93.LA-XX-A | Amputation, other phalanx of hand using autograft [e.g., full-thickness skin graft or bone graft] (for closure of stump) |
1.UJ.93.LA-XX-B | Amputation, other phalanx of hand using split-thickness skin graft (for closure of stump) |
1.UJ.93.LA-XX-E | Amputation, other phalanx of hand using local flap [e.g., V–Y plasty] |
1.UJ93.LA-XX-F | Amputation, other phalanx of hand using free flap [e.g., toe-to-finger flap] |
1.UJ93.LA-XX-G | Amputation, other phalanx of hand using pedicled transposition flap [e.g., finger rotation flap] |
1.WI.93 | Amputation, first metatarsal bone and first metatarsophalangeal joint |
1.WI.93.LA | Amputation, first metatarsal bone and first metatarsophalangeal joint using open approach (with or without simple apposition for closure of stump) |
1.WI.93.LA-XX-A | Amputation, first metatarsal bone and first metatarsophalangeal joint using skin autograft (for closure of stump) |
1.WI.93.LA-XX-E | Amputation, first metatarsal bone and first metatarsophalangeal joint using local flap (for closure of stump) |
1.WJ.93 | Amputation, tarsometatarsal joints, metatarsal bones and metatarsophalangeal joints [forefoot] |
1.WJ.93.LA | Amputation, tarsometatarsal joints, other metatarsal bones and other metatarsophalangeal joints [forefoot] using open approach (with or without simple apposition for closure of stump) |
1.WJ.93.LA-XX-A | Amputation, tarsometatarsal joints, other metatarsal bones and other metatarsophalangeal joints [forefoot] using skin autograft (for closure of stump) |
1.WJ.93.LA-XX-E | Amputation, tarsometatarsal joints, other metatarsal bones and other metatarsophalangeal joints [forefoot] using local flap (for closure of stump) |
1.WK.93 | Amputation, first phalanx of foot |
1.WK.93.LA | Amputation, first phalanx of foot using simple apposition technique [e.g., suturing] (for closure of stump) |
1.WK.93.LA-XX-A | Amputation, first phalanx of foot using skin graft (for closure of stump) |
1.WK.93.LA-XX-G | Amputation, first phalanx of foot using pedicled transposition flap [e.g., toe rotation flap] |
1.WL.93 | Amputation, phalanx of foot |
1.WL.93.LA | Amputation, other phalanx of foot using simple apposition technique [e.g., suturing] (for closure of stump) |
1.WL.93.LA-XX-A | Amputation, other phalanx of foot using skin graft (for closure of stump) |
1.WL.93.LA-XX-G | Amputation, other phalanx of foot using pedicled transposition flap [e.g., toe rotation flap] |
1.YA.80 | Repair, scalp |
1.YA.80.JA-XX-K | Repair, scalp using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YA.80.JA-XX-P | Repair, scalp using cultured tissue |
1.YA.80.LA-XX-A | Repair, scalp using full-thickness autograft |
1.YA.80.LA-XX-B | Repair, scalp using split-thickness autograft |
1.YA.80.LA-XX-E | Repair, scalp using local flap [e.g., rotation, advancement, juri, Z-plasty] |
1.YA.80.LA-XX-F | Repair, scalp using free flap [e.g., fasciocutaneous] |
1.YA.87 | Excision partial, scalp |
1.YA.87.LA-AY-A | Excision partial, scalp open [excisional] approach and dermatome using full-thickness autograft |
1.YA.87.LA-AY-B | Excision partial, scalp open [excisional] approach and dermatome using split-thickness autograft |
1.YA.87.LA-AY-E | Excision partial, scalp open [excisional] approach and dermatome using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YA.87.LA-AY-F | Excision partial, scalp open [excisional] approach and dermatome using free flap |
1.YA.87.LA-XX-A | Excision partial, scalp open [excisional] approach using full-thickness autograft |
1.YA.87.LA-XX-B | Excision partial, scalp open [excisional] approach using split-thickness autograft |
1.YA.87.LA-XX-E | Excision partial, scalp open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YA.87.LA-XX-F | Excision partial, scalp open [excisional] approach using free flap |
1.YB.80 | Repair, skin of forehead |
1.YB.80.JA-XX-K | Repair, skin of forehead using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YB.80.JA-XX-P | Repair, skin of forehead using cultured tissue |
1.YB.80.LA-XX-A | Repair, skin of forehead using full-thickness autograft |
1.YB.80.LA-XX-B | Repair, skin of forehead using split-thickness autograft |
1.YB.80.LA-XX-E | Repair, skin of forehead using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YB.80.LA-XX-F | Repair, skin of forehead using free flap [e.g., microvascular free flap] |
1.YB.87 | Excision partial, skin of forehead |
1.YB.87.LA-AY-A | Excision partial, skin of forehead open [excisional] approach and dermatome using full-thickness autograft |
1.YB.87.LA-AY-B | Excision partial, skin of forehead open [excisional] approach and dermatome using split-thickness autograft |
1.YB.87.LA-AY-E | Excision partial, skin of forehead open [excisional] approach and dermatome using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YB.87.LA-AY-F | Excision partial, skin of forehead open [excisional] approach and dermatome using free flap |
1.YB.87.LA-AY-P | Excision partial, skin of forehead open [excisional] approach and dermatome using cultured tissue |
1.YB.87.LA-XX-A | Excision partial, skin of forehead open [excisional] approach using full-thickness autograft |
1.YB.87.LA-XX-B | Excision partial, skin of forehead open [excisional] approach using split-thickness autograft |
1.YB.87.LA-XX-E | Excision partial, skin of forehead open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YB.87.LA-XX-F | Excision partial, skin of forehead open [excisional] approach using free flap |
1.YB.87.LA-XX-P | Excision partial, skin of forehead open [excisional] approach using cultured tissue |
1.YC.80 | Repair, skin of ear |
1.YC.80.JA-XX-K | Repair, skin of ear using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YC.80.JA-XX-P | Repair, skin of ear using cultured tissue |
1.YC.80.LA-XX-A | Repair, skin of ear using full-thickness autograft |
1.YC.80.LA-XX-B | Repair, skin of ear using split-thickness autograft |
1.YC.80.LA-XX-E | Repair, skin of ear using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YC.87 | Excision partial, skin of ear |
1.YC.87.LA-XX-A | Excision partial, skin of ear open [excisional] approach using full-thickness autograft |
1.YC.87.LA-XX-B | Excision partial, skin of ear open [excisional] approach using split-thickness autograft |
1.YC.87.LA-XX-E | Excision partial, skin of ear open [excisional] approach using local flap |
1.YD.80 | Repair, skin of nose |
1.YD.80.JA-XX-K | Repair, skin of nose using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YD.80.JA-XX-P | Repair, skin of nose using cultured tissue |
1.YD.80.LA-XX-A | Repair, skin of nose using full-thickness autograft |
1.YD.80.LA-XX-B | Repair, skin of nose using split-thickness autograft |
1.YD.80.LA-XX-E | Repair, skin of nose using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YD.80.LA-XX-F | Repair, skin of nose using free flap |
1.YD.87 | Excision partial, skin of nose |
1.YD.87.LA-AY-A | Excision partial, skin of nose open [excisional] approach and dermatome using full-thickness autograft |
1.YD.87.LA-AY-B | Excision partial, skin of nose open [excisional] approach and dermatome using split-thickness autograft |
1.YD.87.LA-AY-E | Excision partial, skin of nose open [excisional] approach and dermatome using local flap [e.g., advancement flap] |
1.YD.87.LA-XX-A | Excision partial, skin of nose open [excisional] approach using full-thickness autograft |
1.YD.87.LA-XX-B | Excision partial, skin of nose open [excisional] approach using split-thickness autograft |
1.YD.87.LA-XX-E | Excision partial, skin of nose open [excisional] approach using local flap [e.g., advancement, transposition or rotation flap] |
1.YE.80 | Repair, lip |
1.YE.80.LA-XX-A | Repair, lip using full-thickness autograft |
1.YE.80.LA-XX-B | Repair, lip using split-thickness autograft |
1.YE.80.LA-XX-E | Repair, lip using local flap [e.g., rotation, advancement, transposition, Zplasty, Millard] |
1.YE.80.LA-XX-K | Repair, lip using homograft (e.g., alloderm) |
1.YE.87 | Excision partial, lip |
1.YE.87.LA-XX-E | Excision partial, lip using open [excisional] approach with local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YE.87.WJ | Excision partial, lip using open wedge resection approach with apposition technique (e.g., suture, glue) for closure |
1.YE.87.WJ-XX-E | Excision partial, lip using open wedge resection with local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YF.80 | Repair, skin of face |
1.YF.80.JA-XX-K | Repair, skin of face using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YF.80.JA-XX-P | Repair, skin of face using cultured tissue |
1.YF.80.LA | Repair, skin of face using apposition technique [suture] |
1.YF.80.LA-XX-A | Repair, skin of face using full-thickness autograft |
1.YF.80.LA-XX-B | Repair, skin of face using split-thickness autograft |
1.YF.80.LA-XX-E | Repair, skin of face using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YF.80.LA-XX-F | Repair, skin of face using free flap [e.g., microvascular free flap] |
1.YF.80.LA-XX-G | Repair, skin of face using pedicled flap |
1.YF.87 | Excision partial, skin of face |
1.YF.87.LA | Excision partial, skin of face open [excisional] approach with apposition technique (e.g., suture, glue) for closure |
1.YF.87.LA-AY | Excision partial, skin of face open [excisional] approach and dermatome with apposition technique (e.g., suture, glue) for closure |
1.YF.87.LA-AY-A | Excision partial, skin of face open [excisional] approach and dermatome using full-thickness autograft |
1.YF.87.LA-AY-B | Excision partial, skin of face open [excisional] approach and dermatome using split-thickness autograft |
1.YF.87.LA-AY-E | Excision partial, skin of face open [excisional] approach and dermatome using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YF.87.LA-AY-F | Excision partial, skin of face open [excisional] approach and dermatome using free flap for closure |
1.YF.87.LA-XX-A | Excision partial, skin of face open [excisional] approach using full-thickness autograft |
1.YF.87.LA-XX-B | Excision partial, skin of face open [excisional] approach using split-thickness autograft |
1.YF.87.LA-XX-E | Excision partial, skin of face open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YF.87.LA-XX-F | Excision partial, skin of face open [excisional] approach using free flap for closure |
1.YG.80 | Repair, skin of neck |
1.YG.80.JA-XX-K | Repair, skin of neck using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YG.80.JA-XX-P | Repair, skin of neck using cultured tissue |
1.YG.80.LA | Repair, skin of neck using apposition technique [suture] |
1.YG.80.LA-XX-A | Repair, skin of neck using full-thickness autograft |
1.YG.80.LA-XX-B | Repair, skin of neck using split-thickness autograft |
1.YG.80.LA-XX-E | Repair, skin of neck using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YG.80.LA-XX-F | Repair, skin of neck using free flap [e.g., microvascular free flap] |
1.YG.87 | Excision partial, skin of neck |
1.YG.87.LA | Excision partial, skin of neck open [excisional] approach with apposition technique (e.g., suture, glue) for closure |
1.YG.87.LA-AY | Excision partial, skin of neck open [excisional] approach and dermatome with apposition technique (e.g., suture, glue) for closure |
1.YG.87.LA-AY-A | Excision partial, skin of neck open [excisional] approach and dermatome using full-thickness autograft |
1.YG.87.LA-AY-B | Excision partial, skin of neck open [excisional] approach and dermatome using split-thickness autograft |
1.YG.87.LA-AY-E | Excision partial, skin of neck open [excisional] approach and dermatome using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YG.87.LA-AY-F | Excision partial, skin of neck open [excisional] approach and dermatome using free flap |
1.YG.87.LA-XX-A | Excision partial, skin of neck open [excisional] approach using full-thickness autograft |
1.YG.87.LA-XX-B | Excision partial, skin of neck open [excisional] approach using split-thickness autograft |
1.YG.87.LA-XX-E | Excision partial, skin of neck open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YG.87.LA-XX-F | Excision partial, skin of neck open [excisional] approach using free flap |
1.YR.80 | Repair, skin of axillary region |
1.YR.80.JA-FF | Repair, skin of axillary region using closure device (e.g., clip, adhesive skin closure [Steri-Strips]) |
1.YR.80.JA-XX-K | Repair, skin of axillary region using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YR.80.JA-XX-P | Repair, skin of axillary region using cultured tissue |
1.YR.80.LA | Repair, skin of axillary region using apposition technique [suture] |
1.YR.80.LA-XX-A | Repair, skin of axillary region using full-thickness autograft |
1.YR.80.LA-XX-B | Repair, skin of axillary region using split-thickness autograft |
1.YR.80.LA-XX-E | Repair, skin of axillary region using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YR.80.LA-XX-F | Repair, skin of axillary region using free flap [e.g., microvascular free flap] |
1.YR.87 | Excision partial, skin of axillary region |
1.YR.87.LA | Excision partial, skin of axillary region open [excisional] approach with apposition technique (e.g., suture, glue) for closure |
1.YR.87.LA-AY | Excision partial, skin of axillary region open [excisional] approach and dermatome with apposition technique (e.g., suture, glue) for closure |
1.YR.87.LA-AY-A | Excision partial, skin of axillary region open [excisional] approach and dermatome using full-thickness autograft |
1.YR.87.LA-AY-B | Excision partial, skin of axillary region open [excisional] approach and dermatome using split-thickness autograft |
1.YR.87.LA-AY-E | Excision partial, skin of axillary region open [excisional] approach and dermatome using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YR.87.LA-XX-A | Excision partial, skin of axillary region open [excisional] approach using full-thickness autograft |
1.YR.87.LA-XX-B | Excision partial, skin of axillary region open [excisional] approach using split-thickness autograft |
1.YR.87.LA-XX-E | Excision partial, skin of axillary region open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YS.80 | Repair, skin of abdomen and trunk |
1.YS.80.JA-FF | Repair, skin of abdomen and trunk using closure device (e.g., clip, adhesive skin closure [Steri-Strips]) |
1.YS.80.JA-XX-K | Repair, skin of abdomen and trunk using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YS.80.JA-XX-P | Repair, skin of abdomen and trunk using cultured tissue |
1.YS.80.LA | Repair, skin of abdomen and trunk using apposition technique [suture] |
1.YS.80.LA-XX-A | Repair, skin of abdomen and trunk using full-thickness autograft |
1.YS.80.LA-XX-B | Repair, skin of abdomen and trunk using split-thickness autograft |
1.YS.80.LA-XX-E | Repair, skin of abdomen and trunk using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YS.80.LA-XX-F | Repair, skin of abdomen and trunk using free flap [e.g., fasciocutaneous free flap] |
1.YS.87 | Excision partial, skin of abdomen and trunk |
1.YS.87.LA | Excision partial, skin of abdomen and trunk open [excisional] approach with apposition technique (suture, glue) for closure |
1.YS.87.LA-AY | Excision partial, skin of abdomen and trunk open [excisional] approach and dermatome with apposition technique (suture, glue) for closure |
1.YS.87.LA-AY-A | Excision partial, skin of abdomen and trunk open [excisional] approach and dermatome using full-thickness autograft |
1.YS.87.LA-AY-B | Excision partial, skin of abdomen and trunk open [excisional] approach and dermatome using split-thickness autograft |
1.YS.87.LA-AY-E | Excision partial, skin of abdomen and trunk open [excisional] approach and dermatome using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YS.87.LA-AY-F | Excision partial, skin of abdomen and trunk open [excisional] approach and dermatome using free flap |
1.YS.87.LA-XX-A | Excision partial, skin of abdomen and trunk open [excisional] approach using full-thickness autograft |
1.YS.87.LA-XX-B | Excision partial, skin of abdomen and trunk open [excisional] approach using split-thickness autograft |
1.YS.87.LA-XX-E | Excision partial, skin of abdomen and trunk open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YS.87.LA-XX-F | Excision partial, skin of abdomen and trunk open [excisional] approach using free flap |
1.YT.80 | Repair, skin of arm |
1.YT.80.JA-FF | Repair, skin of arm using closure device (e.g., clip, adhesive skin closure [Steri-Strips]) |
1.YT.80.JA-XX-K | Repair, skin of arm using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YT.80.JA-XX-P | Repair, skin of arm using cultured tissue |
1.YT.80.LA | Repair, skin of arm using apposition technique [suture] |
1.YT.80.LA-XX-A | Repair, skin of arm using full-thickness autograft |
1.YT.80.LA-XX-B | Repair, skin of arm using split-thickness autograft |
1.YT.80.LA-XX-E | Repair, skin of arm using local flap [e.g., rotational, V Y advancement, transposition, Z plasty, Cutler flap] |
1.YT.80.LA-XX-F | Repair, skin of arm using free flap [e.g., microvascular free flap] |
1.YT.80.LA-XX-G | Repair, skin of arm using pedicled (distant)flap |
1.YT.87 | Excision partial, skin of arm |
1.YT.87.LA | Excision partial, skin of arm open [excisional] approach with apposition technique (suture, glue) for closure |
1.YT.87.LA-AY | Excision partial, skin of arm open [excisional] approach and dermatome with apposition technique (suture, glue) for closure |
1.YT.87.LA-AY-A | Excision partial, skin of arm open [excisional] approach and dermatome using full-thickness autograft |
1.YT.87.LA-AY-B | Excision partial, skin of arm open [excisional] approach and dermatome using split-thickness autograft |
1.YT.87.LA-AY-E | Excision partial, skin of arm open [excisional] approach and dermatome using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YT.87.LA-AY-F | Excision partial, skin of arm open [excisional] approach and dermatome using free flap |
1.YT.87.LA-XX-A | Excision partial, skin of arm open [excisional] approach using full-thickness autograft |
1.YT.87.LA-XX-B | Excision partial, skin of arm open [excisional] approach using split-thickness autograft |
1.YT.87.LA-XX-E | Excision partial, skin of arm open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YT.87.LA-XX-F | Excision partial, skin of arm open [excisional] approach using free flap |
1.YU.80 | Repair, skin of hand |
1.YU.80.JA-XX-K | Repair, skin of hand using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YU.80.JA-XX-P | Repair, skin of hand using cultured tissue |
1.YU.80.LA-XX-A | Repair, skin of hand using full-thickness autograft |
1.YU.80.LA-XX-B | Repair, skin of hand using split-thickness autograft |
1.YU.80.LA-XX-E | Repair, skin of hand using local flap [e.g., rotational, V Y advancement, transposition, Z plasty, Cutler flap] |
1.YU.80.LA-XX-F | Repair, skin of hand using free flap |
1.YU.80.LA-XX-G | Repair, skin of hand using pedicled (distant) flap |
1.YU.87 | Excision partial, skin of hand |
1.YU.87.LA-XX-A | Excision partial, skin of hand open [excisional] approach using full-thickness autograft |
1.YU.87.LA-XX-B | Excision partial, skin of hand open [excisional] approach using split-thickness autograft |
1.YU.87.LA-XX-E | Excision partial, skin of hand open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YU.87.LA-XX-F | Excision partial, skin of hand open (excisional) approach using free flap |
1.YV.80 | Repair, skin of leg |
1.YV.80.JA-FF | Repair, skin of leg using closure device (e.g., clip, adhesive skin closure [Steri-Strips]) |
1.YV.80.JA-XX-K | Repair, skin of leg using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YV.80.JA-XX-P | Repair, skin of leg using cultured tissue |
1.YV.80.LA | Repair, skin of leg using apposition technique [suture] |
1.YV.80.LA-XX-A | Repair, skin of leg using full-thickness autograft |
1.YV.80.LA-XX-B | Repair, skin of leg using split-thickness autograft |
1.YV.80.LA-XX-E | Repair, skin of leg using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YV.80.LA-XX-F | Repair, skin of leg using free flap [e.g., fasciocutaneous flap] |
1.YV.87 | Excision partial, skin of leg |
1.YV.87.LA | Excision partial, skin of leg open [excisional] approach with apposition technique (suture, glue) for closure |
1.YV.87.LA-AY | Excision partial, skin of leg open [excisional] approach and dermatome with apposition technique (suture, glue) for closure |
1.YV.87.LA-AY-A | Excision partial, skin of leg open [excisional] approach and dermatome using full-thickness autograft |
1.YV.87.LA-AY-B | Excision partial, skin of leg open [excisional] approach and dermatome using split-thickness autograft |
1.YV.87.LA-AY-E | Excision partial, skin of leg open [excisional] approach and dermatome using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YV.87.LA-AY-F | Excision partial, skin of leg open [excisional] approach and dermatome using free flap |
1.YV.87.LA-XX-A | Excision partial, skin of leg open [excisional] approach using full-thickness autograft |
1.YV.87.LA-XX-B | Excision partial, skin of leg open [excisional] approach using split-thickness autograft |
1.YV.87.LA-XX-E | Excision partial, skin of leg open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YV.87.LA-XX-F | Excision partial, skin of leg open [excisional] approach using free flap |
1.YW.80 | Repair, skin of foot |
1.YW.80.JA-XX-K | Repair, skin of foot using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YW.80.JA-XX-P | Repair, skin of foot using cultured tissue |
1.YW.80.LA-XX-A | Repair, skin of foot using full-thickness autograft |
1.YW.80.LA-XX-B | Repair, skin of foot using split-thickness autograft |
1.YW.80.LA-XX-E | Repair, skin of foot using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YW.80.LA-XX-F | Repair, skin of foot using free flap [e.g., fasciocutaneous] |
1.YW.87 | Excision partial, skin of foot |
1.YW.87.LA-XX-A | Excision partial, skin of foot open [excisional] approach using full-thickness autograft |
1.YW.87.LA-XX-B | Excision partial, skin of foot open [excisional] approach using split-thickness autograft |
1.YW.87.LA-XX-E | Excision partial, skin of foot open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YZ.80 | Repair, skin NEC |
1.YZ.80.JA-FF | Repair, skin NEC using closure device (e.g., clip, adhesive skin closure [Steri-Strips]) |
1.YZ.80.JA-XX-K | Repair, skin NEC using homograft (e.g., GRAFTJACKET regenerative tissue matrix) |
1.YZ.80.JA-XX-P | Repair, skin NEC using cultured tissue |
1.YZ.80.LA | Repair, skin NEC using apposition technique [suture] |
1.YZ.80.LA-XX-A | Repair, skin NEC using full-thickness autograft |
1.YZ.80.LA-XX-B | Repair, skin NEC using split-thickness autograft |
1.YZ.80.LA-XX-E | Repair, skin NEC using local flap [e.g., rotation, advancement, transposition, Z-plasty] |
1.YZ.80.LA-XX-F | Repair, skin NEC using open approach and free flap [e.g., microvascular free flap] |
1.YZ.87 | Excision partial, skin NEC |
1.YZ.87.LA | Excision partial, skin NEC open [excisional] approach with apposition technique (suture, glue) for closure |
1.YZ.87.LA-AY | Excision partial, skin NEC open [excisional] approach and dermatome with apposition technique (suture, glue) for closure |
1.YZ.87.LA-AY-A | Excision partial, skin NEC open [excisional] approach and dermatome using full-thickness autograft |
1.YZ.87.LA-AY-B | Excision partial, skin NEC open [excisional] approach and dermatome using split-thickness autograft |
1.YZ.87.LA-AY-E | Excision partial, skin NEC open [excisional] approach and dermatome using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YZ.87.LA-AY-F | Excision partial, skin NEC open [excisional] approach and dermatome using free flap |
1.YZ.87.LA-XX-A | Excision partial, skin NEC open [excisional] approach using full-thickness autograft |
1.YZ.87.LA-XX-B | Excision partial, skin NEC open [excisional] approach using split-thickness autograft |
1.YZ.87.LA-XX-E | Excision partial, skin NEC open [excisional] approach using local flap [e.g., rotation, advancement, transposition, Z-plasty] for closure |
1.YZ.87.LA-XX-F | Excision partial, skin NEC open [excisional] approach using free flap |
Radiation CCI procedure codes
Local
Code | Fee code description |
|---|---|
1.YF.27 | Radiation, skin of face |
1.YS.27 | Radiation, skin of abdomen and trunk |
1.YT.27 | Radiation, skin of arm |
1.YV.27 | Radiation, skin of leg |
1.YZ.27 | Radiation, skin NEC |
Regional
Code | Fee code description |
|---|---|
1.MD.27 | Radiation, lymph node(s), axillary |
1.MH.27 | Radiation, lymph node(s), pelvic |
1.MJ.27 | Radiation, lymph node(s), inguinal |
Metastases
Code | Fee code description |
|---|---|
1.AN.27 | Radiation, brain |
1.AW.27 | Radiation, spinal cord |
1.EA.27 | Radiation, cranium |
1.Equation 27 | Radiation, soft tissue of head and neck |
1.GT.27 | Radiation, lung NEC |
1.MF.27 | Radiation, lymph node(s), intrathoracic NEC |
1.MH.27 | Radiation, lymph node(s), pelvic |
1.PB.27 | Radiation, adrenal gland |
1.PC.27 | Radiation, kidney |
1.SC.27 | Radiation, spinal vertebrae |
1.SH.27 | Radiation, soft tissue of the back |
1.SL.27 | Radiation, ribs |
1.SQ.27 | Radiation, pelvis |
1.SZ.27 | Radiation, soft tissue of the chest and abdomen |
1.TX.27 | Radiation, soft tissue of arm NEC |
1.TZ.27 | Radiation, arm NEC |
1.VX.27 | Radiation, soft tissue of leg |
1.VZ.27 | Radiation, leg NEC |
1.WZ.27 | Radiation, Musculoskeletal system NEC |
1.YM.27 | Radiation, breast |
Chemotherapy DINs
DIN | Description | |
|---|---|---|
02241093 | TEMOZOLOMIDE | |
02241094 | TEMOZOLOMIDE | |
02241095 | TEMOZOLOMIDE | |
02241096 | TEMOZOLOMIDE | |
02312794 | TEMOZOLOMIDE | |
02312816 | TEMOZOLOMIDE | |
02380242 | VEMURAFENIB | |
02395274 | TEMOZOLOMIDE | |
02395282 | TEMOZOLOMIDE | |
02395290 | TEMOZOLOMIDE | |
02395312 | TEMOZOLOMIDE | |
02409607 | DABRAFENIB | |
02409615 | DABRAFENIB | |
02409623 | TRAMETINIB RECOMBINANT | |
02409658 | TRAMETINIB RECOMBINANT | |
02441152 | PEMBROLIZUMAB | |
Chemotherapy OHIP fee codes
Code | Fee code description |
|---|---|
G281 | D./T. PROC.INJ/INF-INTRAVEN-CHEMOTHERAPY-EA.ADD.INJ.TO G381 |
G345 | D&T MULT.AGENTS CHEMOTHER.GREATER THAN 10 UNITS PER MET.SQ |
G359 | D&T SING.AGENT CHEMOTHER.(GREATER THAN 2G/M2 OR 1G/M2.) |
G381 | D./T. PROC. INJECT/INFUS. INTRAVENOUS CHEMOTHERAPY-1ST INJ |
Inadequate surgery OHIP fee codes
Code | Fee code description |
|---|---|
E300 | EAR-EXT.-EXC-RESECT.PINNA-WITH PRIMARY CLOSURE |
E301 | EAR-EXT.-EXC-RESECT.PINNA-WITH LOCAL FLAP |
E540 | SKIN-MALIG.LESION-EXC-IN HOSP-TUMOUR FREE MARGIN ADD 25% |
E542 | ADD ON CODE TO SERVICES WHEN PERFORMED OUTSIDE HOSPITAL |
M012 | NOSE-EXC.-SEPTUM-SUBMUCOUS RESECTION INCL. SEPTOPLASTY |
R018 | SKIN-CURRET-ELECTRO DESIC/CRYOSURG-LOC.MALIG-FACE/NECK-1 LES |
R019 | SKIN-CURRET/ELECTRO DESIC/CRYOSURG-LOC.MALIG-FACE/NECK-2 LES |
R020 | SKIN-CURRET/ELECTRO DESIC/CRYOSURG-LOC.MALIG-FACE/NECK-3/MOR |
R031 | SKIN & SUBCUT.TISSUE-CURETT.& ELECTRODES.LOC MALIG.1 LESION |
R032 | SKIN & SUBCUT.TISSUE-CURETT.& ELECTRODES.LOC MALIG 2 LESIONS |
R033 | SKIN & SUBCUT.TISS.-CURET.& ELECTRO-LOC MALIG-3/MORE LESIONS |
R040 | SKIN-EXC/CURET + DESSICAT./CRYOSURG.INCL.BIOPSY LOCAL.MALIG.-2 |
R041 | SKIN-EXC/CURET + DESSICAT/CRYOSURG.INCL.BIOP.LOCAL MALIG3/MORE |
R048 | SKIN-EXC.-LOC.MALIG.INCL.BIOPSY-FACE/NECK-1 LESION. |
R049 | SKIN-EXC.-LOC.MALIG.INCL.BIOPSY-FACE/NECK-2 LESIONS |
R050 | SKIN-EXC.-LOC.MALIG.INCL.BIOPSY-FACE/NECK-3/MORE LESIONS. |
R094 | SKIN-EXC-SIMPLE-MALIG.LESION-OTHER AREA-INCL.BIOPSY-ONE |
R160 | Pre-malignant lesions including biopsy of each lesion—face or neck—simple excision—single lesion |
R161 | Face or neck—simple excision—two lesions |
R162 | Face or neck—simple excision—three or more lesions |
R163 | Pre-malignant lesions including biopsy of each lesion—other areas—simple excision—single lesion |
R164 | Other areas—simple excision—two lesions |
R165 | Other areas—simple excision—three or more lesions |
R993 | TUMOUR-EXCISION-NOT SPECIFICALLY LISTED-I.C. |
S010 | LIPS-EXC.-WEDGE RESECTION & PLASTIC REPAIR |
S011 | LIPS-EXC.-WEDGE RESECTION VERMILLION. |
S249 | ANUS-EXC.-LOCAL FOR MALIGNANCY |
Z080 | Debridement of wound(s) and/or ulcer(s) extending into subcutaneous tissue—one |
Z081 | Debridement of wound(s) and/or ulcer(s) extending into subcutaneous tissue—two |
Z082 | Debridement of wound(s) and/or ulcer(s) extending into subcutaneous tissue—three |
Z083 | Debridement of wound(s) and/or ulcer(s) extending into subcutaneous tissue—four or more |
Z084 | Debridement of wound(s) and/or ulcer(s) extending into any of the following structures: tendon, ligament, bursa and/or bone—one |
Z085 | Debridement of wound(s) and/or ulcer(s) extending into any of the following structures: tendon, ligament, bursa and/or bone—two or more |
Z117 | SKIN.CHEM/CRYOTHERAPY MINOR SKIN LESIONS 1/MORE |
Z123 | SKIN-EXC.-GROUP 4-FACE/NECK-TWO LESIONS-LOC. ANAES. |
Z128 | SKIN-DESTRUCTION FINGER/TOENAIL PART/COMP./NAIL PLATE EXC.1 |
Z129 | SKIN-DESTRUCTION-FINGER/TOENAIL-SIMPLE-PART/COMPL.-MULTI |
Z162 | SKIN-EXC-SUT.-NAEVUS-ONE. |
Z163 | SKIN-EXC-SUT.-NAEVUS-TWO. |
Z164 | SKIN-EXC-SUT.-NAEVUS-THREE/MORE. |
Z165 | SKIN-EXC-SUT.-NAEVUS-CONGENITAL-EXTENSIVE. |
Z166 | SKIN-EXC-SUT.-PLANTAR-ONE. |
Z169 | SKIN & SUBCUT.-PLANTAR-REMOVAL BY ELECTRO.-SINGLE LESION |
Z170 | SKIN & SUBCUT.-PLANTAR-REMOVAL BY ELECTRO.-TWO LESIONS |
Z171 | SKIN & SUBCUT.-PLANTAR-REMOVAL BY ELECTRO-THREE/MORE LESIONS |
Z502 | MOUTH-EXC-LESION-LESS THAN 2CM. |
Z504 | LIPS-EXC.-LESION |
Biopsy OHIP fee codes
Code | Fee code description |
|---|---|
E172 | EYE ORBIT-EXC.-BIOPSY-ANTERIOR ROUTE |
E542 | ADD ON CODE TO SERVICES WHEN PERFORMED OUTSIDE HOSPITAL |
Z113 | INTEGUMENTARY SYST.BIOPSY(S)-ANY METHOD, SUTURES NOT USED |
Z116 | SURG.PROC SKIN-BIOPSY(S)ANY METHOD WHEN SUTURES USED |
Z155 | SKIN-INC.-BIOPSY EXTENSIVE/COMPLICATED/GEN.ANAES.-SOLE PROC |
Z309 | NOSE-EXC.-BIOPSY-LOC. ANAES |
Z405 | LYMPHATIC-NODES-EXC.-BIOPSY-CERVICAL,AXILLARY,INGUINAL |
Z406 | LYMPHATIC-NODES-EXC.-BIOPSY-SCALENE |
Z411 | Axillary or inguinal lymph node(s), unilateral |
Z475 | VULVA & INTROITUS-EXCISION-BIOPSY-GEN.ANAESTHETIC |
Z477 | VULVA & INTROITUS-EXCISION-BIOPSY-LOC.ANAESTHETIC |
Z501 | MOUTH-INC.-BIOPSY |
Z503 | LIPS-INC.-BIOPSY |
Z544 | ANUS-INC. BIOPSY |
Z702 | PENIS-EXC.-BIOPSY |
Z722 | VAGINA-EXC.-BIOPSY-LOCAL ANAESTHETIC-SOLE PROCEDURE |
Rights and permissions
About this article
Cite this article
Austin, J., Wright, F.C., Cheng, S.Y. et al. Outcomes of Immunosuppressed Patients Who Develop Melanoma: A Population-Based Propensity-Matched Cohort Study. Ann Surg Oncol 27, 2927–2948 (2020). https://doi.org/10.1245/s10434-020-08265-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08265-4